Katja Deterding Selected Research

Katja Deterding Research Topics

Disease

34	Infections 03/2023 - 10/2006
15	Fibrosis (Cirrhosis) 03/2024 - 05/2011
15	Hepatitis C 03/2023 - 11/2008
12	Chronic Hepatitis C 01/2022 - 01/2009
11	Chronic Hepatitis B 11/2016 - 10/2007
8	Liver Diseases (Liver Disease) 03/2024 - 01/2009
8	Hepatitis D 04/2023 - 06/2010
7	Hepatocellular Carcinoma (Hepatoma) 04/2023 - 10/2012
6	Virus Diseases (Viral Diseases) 12/2023 - 07/2009
6	Hepatitis B 12/2023 - 04/2010
6	Hepatitis 04/2023 - 10/2007
4	Liver Cirrhosis (Hepatic Cirrhosis) 03/2024 - 08/2014
4	Chronic Hepatitis D 03/2024 - 01/2023
3	Portal Hypertension 03/2024 - 01/2021
3	Hemorrhage 12/2023 - 01/2017
3	Neoplasms (Cancer) 01/2021 - 08/2015
3	Disease Progression 01/2017 - 10/2008
2	Ascites 12/2023 - 01/2017
2	Brain Diseases (Brain Disorder) 12/2023 - 01/2017
2	Inflammation (Inflammations) 01/2022 - 01/2021
2	Coinfection 07/2021 - 11/2008
2	Non-alcoholic Fatty Liver Disease 01/2021 - 12/2016
2	Chronic Hepatitis (Chronic Active Hepatitis) 01/2019 - 09/2014
1	Varicose Veins (Varicose Vein) 03/2024
1	Metabolic Diseases (Metabolic Disease) 12/2023
1	End Stage Liver Disease 04/2023
1	Carcinoma (Carcinomatosis) 01/2021
1	Autoimmune Hepatitis 01/2021
1	Sclerosing Cholangitis 01/2021
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2021
1	Reinfection 11/2019
1	Diabetes Mellitus 09/2017
1	Weight Gain 09/2017
1	Fatty Liver 12/2016
1	Budd-Chiari Syndrome (Budd Chiari Syndrome) 08/2015
1	HIV Infections (HIV Infection) 10/2011

Drug/Important Bio-Agent (IBA)

22	Antiviral Agents (Antivirals)IBA 03/2024 - 10/2006
13	InterferonsIBA 04/2023 - 07/2009
12	RNA (Ribonucleic Acid)IBA 01/2023 - 12/2006
9	Interferon-alpha (Interferon Alfa)IBA 01/2023 - 10/2006
9	Ribavirin (Virazole)FDA LinkGeneric 01/2018 - 10/2006
6	bulevirtideIBA 03/2024 - 01/2019
6	DNA (Deoxyribonucleic Acid)IBA 11/2016 - 10/2007
5	AntigensIBA 01/2023 - 10/2007
5	entecavir FDA Link 11/2016 - 04/2010
4	CytokinesIBA 01/2022 - 05/2014
4	BilirubinIBA 01/2019 - 07/2009
4	Hepatitis B e AntigensIBA 11/2016 - 04/2010
4	Hepatitis B Surface Antigens (HBsAg)FDA Link 11/2016 - 11/2008
3	Alanine Transaminase (SGPT)IBA 04/2023 - 02/2016
3	Tenofovir (Viread)FDA Link 01/2023 - 01/2010
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2017
3	AlbuminsIBA 01/2019 - 08/2014
2	SofosbuvirIBA 03/2023 - 01/2016
2	Protease Inhibitors (Protease Inhibitor)IBA 07/2015 - 08/2014
2	peginterferon alfa-2b (Pegintron)FDA Link 06/2013 - 10/2007
2	NucleosidesIBA 05/2013 - 01/2010
2	NucleotidesIBA 05/2013 - 01/2010
1	4-(3-chlorophenylsulfanyl)piperidineIBA 03/2024
1	velpatasvirIBA 03/2023
1	Anti-Idiotypic AntibodiesIBA 01/2023
1	Bile Acids and Salts (Bile Acids)IBA 01/2023
1	Circular DNAIBA 01/2022
1	sofosbuvir drug combination ledipasvirIBA 01/2022
1	2,6-dinitrotoluene (DNT)IBA 01/2022
1	Interleukin-17 (Interleukin 17)IBA 01/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021
1	Interleukin-10 (Interleukin 10)IBA 01/2021
1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 01/2021
1	Nerve Growth Factor (NGF)IBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	sofosbuvir velpatasvir voxilaprevir drug combinationIBA 09/2020
1	VaccinesIBA 11/2019
1	GlypicansIBA 02/2019
1	Peptides (Polypeptides)IBA 02/2019
1	lonafarnib (SCH 66336)IBA 01/2019
1	myrcludex-BIBA 01/2019
1	TransferasesIBA 01/2019
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2018
1	dasabuvirIBA 01/2017
1	paritaprevirIBA 01/2017
1	Ritonavir (Norvir)FDA Link 01/2017
1	ombitasvirIBA 01/2017
1	ChemokinesIBA 12/2016
1	Blood Proteins (Serum Proteins)IBA 12/2016
1	InterleukinsIBA 11/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2016
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 02/2016
1	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 08/2014
1	telaprevirIBA 08/2014
1	RacivirIBA 10/2011

Therapy/Procedure

22	Therapeutics 12/2023 - 10/2006
6	Liver Transplantation 12/2023 - 10/2006
2	Transplantation 01/2021 - 09/2014
2	Aftercare (After-Treatment) 01/2021 - 01/2018
1	Off-Label Use 03/2024
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2018
1	Drug Therapy (Chemotherapy) 01/2018
1	Retreatment 01/2017
1	Treatment Delay 06/2013